Cutler Group LP Anixa Biosciences Inc Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Cutler Group LP holds 17,500 shares of ANIX stock, worth $53,725. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,500Holding current value
$53,725% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ANIX
# of Institutions
59Shares Held
5.52MCall Options Held
21KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA1.39MShares$4.28 Million0.0% of portfolio
-
D.A. Davidson & Co.671KShares$2.06 Million0.01% of portfolio
-
Laird Norton Trust Company, LLC621KShares$1.91 Million0.26% of portfolio
-
Ubs Group Ag529KShares$1.63 Million0.0% of portfolio
-
Mission Wealth Management, LP470KShares$1.44 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $94.1M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...